Cuizhen Li

Summary

Publications

  1. ncbi request reprint Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations
    Cuizhen Li
    Riverside Methodist Hospital, 3535 Olentangy River Road, Columbus, OH 43214, USA
    Mod Pathol 20:1263-8. 2007
  2. ncbi request reprint Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study
    Zhong Jiang
    University of Massachusetts Medical Center, Department of Pathology, Worcester, MA, USA
    Lancet Oncol 7:556-64. 2006
  3. ncbi request reprint IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression
    Cuizhen Li
    Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA
    Mod Pathol 20:242-7. 2007
  4. ncbi request reprint Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens
    Zhong Jiang
    Department of Pathology, University of Massachusetts Medical School, Worcester 01655, USA
    Am J Clin Pathol 123:231-6. 2005

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations
    Cuizhen Li
    Riverside Methodist Hospital, 3535 Olentangy River Road, Columbus, OH 43214, USA
    Mod Pathol 20:1263-8. 2007
    ..In addition, expression of IMP3 in endometrioid adenocarcinoma correlates with higher nuclear and architecture grades of the tumor (P=0.0000 and P=0.0002, respectively)...
  2. ncbi request reprint Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study
    Zhong Jiang
    University of Massachusetts Medical Center, Department of Pathology, Worcester, MA, USA
    Lancet Oncol 7:556-64. 2006
    ..We aimed to investigate whether IMP3, an oncofetal RNA-binding protein, can be used as a biomarker to predict metastasis and prognosis of renal-cell carcinoma...
  3. ncbi request reprint IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression
    Cuizhen Li
    Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA
    Mod Pathol 20:242-7. 2007
    ....
  4. ncbi request reprint Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens
    Zhong Jiang
    Department of Pathology, University of Massachusetts Medical School, Worcester 01655, USA
    Am J Clin Pathol 123:231-6. 2005
    ....